TG
ISEE

TCW Group’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

TCW Group’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-16,576
Closed -$1.3M – 704
2015
Q4 		$1.3M Sell
16,576
-1,803
-10% -$104K 0.01% 445
2015
Q3 		$745K Sell
18,379
-712
-4% -$37.7K 0.01% 583
2015
Q2 		$994K Sell
19,091
-6,072
-24% -$302K 0.01% 529
2015
Q1 		$1.17M Sell
25,163
-25,029
-50% -$1.3M 0.01% 697
2014
Q4 		$2.25M Buy
50,192
+3,082
+7% +$129K 0.01% 593
2014
Q3 		$1.83M Sell
47,110
-2,197
-4% -$86.2K 0.01% 676
2014
Q2 		$2.09M Buy
49,307
+742
+2% +$27.2K 0.01% 662
2014
Q1 		$1.74M Sell
48,565
-5,477
-10% -$185K 0.01% 680
2013
Q4 		$1.75M Buy
+54,042
New +$1.6M 0.01% 681

Other funds holding ISEE

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JCG
JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

TCW Group's ISEE Position: Q1 2016 in Review

TCW Group sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2016, closing a stake of 16,576 shares — an estimated $1.3M sold.

TCW Group first reported a position in ISEE in Q4 2013 and held it in 9 quarters. The position peaked at $2.25M in Q4 2014. 162 funds tracked by Wall St. Rank hold ISEE as of Q1 2016.

  • TCW Group reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
  • TCW Group sold 16,576 IVERIC bio, Inc. Common Stock shares in Q1 2016, an estimated $1.3M.
  • TCW Group first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 9 quarters.
  • TCW Group's IVERIC bio, Inc. Common Stock position peaked at $2.25M in Q4 2014.
  • 162 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2016.

Based on TCW Group's 13F filing for Q1 2016, filed 16 May 2016.